BELLEVUE , Wash. , August 30, 2004 --Esterline Corporation ( NYSE /ESL www.esterline.com) a leading specialty manufacturer serving aerospace/defense markets, today announced that it plans to offer 3.2 million shares of its common stock in a public offering.
UBS Securities LLC, Wachovia Capital Markets LLC, and KeyBanc Capital Markets are acting as managing underwriters for the offering. Esterline expects to grant the underwriters an option to purchase 480,000 shares of common stock to cover over-allotments.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission and has become effective. This offering will be made pursuant to a prospectus supplement to the registration statement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor will there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
Copies of the preliminary prospectus relating to this offering of common stock, when available, may be obtained from UBS Securities LLC, 299 Park Avenue, 36 th Floor, New York, New York 10171, attention: Prospectus Department.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the current intent and expectations of the management of Esterline, are not guarantees of future performance, and involve risks and uncertainties that are difficult to predict. Esterline’s actual results and the timing and outcome of events may differ materially from those expressed in or implied by the forward-looking statements due to the risks detailed in the company's public filings with the Securities and Exchange Commission, including the company's Prospectus Supplement dated November 11, 2004